CSI Market
Sign In | Register

Yew Bio pharm Group Inc (YEWB) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access YEWB quarterly Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Yew Bio pharm Group Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
12 Months 		(Dec 31 2019) (Dec 31 2018) (Dec 31 2017) (Dec 31 2016)
Operating Activities
Income1.46
Depreciation & amortization0.06
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed-0.03
Inventories Decrease /-Increase3.47
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets10.07
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Loans, Deferred Income0.21
Sale Of Yew Forest Assets Inventory-
Sale Of Yew Forest Assets As Inventory-
Prepaid Expenses Related Parties-
Increase Decrease In Contract With Customer Liability-0.05
Increase Decrease In Payables To Customers Related Parties-
Amortization Of L and Use Rights And Yew Forest Assets2.76
Increase Decrease In Prepaid Expense Related Parties0.01
Increasing Decreasing Value Added Tax Recoverable0.30
Income taxes-0.12
Losses/ -gains on Investments net0.00
Accounts Receivable-0.65
Increase (Decrease) in Accounts Payable, Trade-0.01
Accrued Expense0.00
Increase (Decrease) in Customer Advances0.00
Increase (Decrease) in Deferred Income Taxes-0.02
Other Working Capital0.00
Other Noncash Income0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.11
Discontinued operations0.00
Net Cash flow from Operating Activities17.34
Investing Activities
Capital Expenditures-0.05
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment To Purchase Of L and Use Rights And Company Assets-12.71
Purchase Of L and Use Rights And Yew Forest Assets-
Purchase Of Yew Forest Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments for Previous Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-4.59
Discontinued operations0.00
Net Cash Flow from Investing Activities-17.36
Financing Activities
Short-term debt Net-0.12
Other borrowing transactions0.00
Long-term debt - borrowings0.03
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Repayment From Directors-
Distribution To Owners Excess Of Acquisition Price Over Carrying Value Of Yew Forest Assets Yew Forest Assets Purchased From Entities Under Common Control-
Contribution From Owners Transfer Of Property And Equipment To Entity Under Common Control With Proceeds Over Carrying Amount-
Distribution To Owners Excess Of Acquisition Price Over Carrying Value Of Yew Forest Assets Purchased From Entities-
Repayments To Related Parties-
Repayment To Related Parties-
Proceeds From Issuance Of Loans0.08
Proceeds From Government Loans-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.01
Effect of exchange rate on cash flow-0.15
Discontinued operations0.00
Free Cash Flow17.29
Total Cash Flow-0.18
4 historic quarters locked

Sign in to unlock the full Yew Bio pharm Group Inc cash flow history.

Sign In Create Free Account

About YEWB Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License